知镜 Cognispect · 医学文献与研究工作台

National Early Warning Score 2-Guided Sepsis Hour-1 Bundle Care for Adults With Suspected Sepsis in the Emergency Department: A Hybrid Type 1 Effectiveness-Implementation Stepped-Wedge Randomized Controlled Trial Pilot Study (NEWS-1 TRIPS).

Lam RPK, Hung KKC, Lui CT, Kwok DWS, Lam WWT, Lau EHY, Sridhar S, Ng PYT, Cheng CH, Siu AYC, Tsang TC, Tsui MSH, Graham CA, Rainer TH.
Critical care medicine · 2026-11-12 · PMID 43018426

文献摘要

Objectives To increase the uptake of the Surviving Sepsis Campaign Hour-1 Bundle, we implemented a novel sepsis care model (National Early Warning Score [NEWS]-1 care), in which the Hour-1 Bundle is objectively triggered by a high NEWS-2 (≥ 5). We aimed to determine the feasibility of a full-scale type 1 hybrid effectiveness-implementation trial of this model. Design A pilot type 1 hybrid trial, comprising a stepped-wedge cluster randomized controlled trial and mixed-methods implementation evaluation with staff focus group interviews and an anonymous survey guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework. Setting Four emergency departments in Hong Kong. Patients Adult patients of 18 years or older with a clinical diagnosis of infection requiring hospitalization and a NEWS-2 greater than or equal to 5. Interventions Implementation of the Hour-1 Bundle when NEWS-2 was greater than or equal to 5. Measurements and main results The primary outcome was the feasibility of a full-scale hybrid trial, evaluated based on 14 progression criteria. Preliminary clinical effectiveness and safety were assessed, alongside implementation barriers and facilitators. During the implementation phase, compliance with lactate, blood culture, and antibiotics increased significantly. All progression criteria were met, except for suboptimal overall bundle compliance (56.1%). Exploratory intention-to-treat analysis (standard care group, n = 102; NEWS-1 group, n = 98) showed no significant between-group difference in 30-day all-cause mortality (standard care group, 3.9%; NEWS-1 group, 9.2%; absolute risk difference, 5.3%; 95% CI -1.6% to 12.1%); in-hospital, 90-day all-cause, or sepsis-related mortality; need for mechanical ventilation, renal replacement therapy, intensive care, or surgery; or ventilator-free days and adverse events. Implementation evaluation identified 15 barriers and 13 facilitators. Conclusions The effectiveness of NEWS-1 care remained uncertain, though adverse events were rare. A full-scale hybrid stepped-wedge trial is feasible but requires a much larger sample size. Real-world implementation barriers and facilitators should be considered in sepsis management guidelines.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。